June 25, 2022
neuriva

Neuriva Settlement 2022: Find Out More!

Did you buy certain Neuriva products from Reckitt for personal or household use, and not for resale or an authorized reseller? Did you buy the Neuriva product in the United States January 1, 2019 and April 23, 2021, the date of Preliminary Approval of the Settlement by the Court, then you may be entitled to a Settlement Benefit.

What is The Neuriva Settlement

 The Neuriva Settlement is Class Action in the amount of $8,000,000 that has been brought against producers of Neuriva® Products, including all variations and sizes of Neuriva Original, Neuriva, Plus, and Neuriva De-Stress. It claimed that they advertised that Neuriva® Products are clinically and scientifically “proven” and such representations are false and misleading.

The Neuriva products include supplements for brain support, focus, memory, and learning. The class action filed against them alleges that Reckitt, the producer of Neuriva products, constitute violations of various states’ consumer protection laws, as well as other laws..

David Williams and others alleged Reckitt Benckiser and RB Health (US) LLC deceptively touted the brain booster as “backed by science” and “clinically proven” to improve brain performance when there is no scientific or clinical proof that Neuriva provides any benefit to the brain.

 Magistrate Judge Jonathan Goodman of the U.S. District Court for the Southern District of Florida approved a deal that provides up to $65 for class members with proof of purchase, and up to $20 for those without.

What is the Lawsuit All about

Plaintiffs have brought this Action against Reckitt Benckiser LLC and RB Health (US) LLC (“Reckitt” or “Defendants”), on behalf of themselves and all other persons who, from January 1, 2019 up to and including April 23, 2021 (the “Class Period”), purchased in the United States for consumption and not resale bottles of Neuriva® Products, including all variations and sizes of Neuriva Original, Neuriva Plus, and Neuriva De-Stress.

Plaintiffs alleged that Defendants advertised that Neuriva® Products are clinically and scientifically “proven” and such representations are false and misleading. Plaintiffs maintain that Defendants actions constitute violations of various states’ consumer protection laws, as well as other laws.

How to know if you are in the settlement class

The Settlement Class includes all individuals that purchased the  purchased, for personal consumption and not for resale, one or more of the covered Neuriva products from Reckitt Benckiser or an authorized reseller in the United States, between Jan. 1, 2019, and April 23, 2021.

The provisions of the Settlement

After final Court approval, every Class Member will be provided monetary or cash payment. Class Members who provide Proof(s) of Purchase may be entitled to recover thirty-two dollars and fifty cents ($32.50) per Valid Claim and may make up to two (2) Claims for a maximum of sixty-five dollars ($65.00).

Conclusion

In addition to the monetary relief, Reckitt Benckiser has agreed to change its labeling and marketing practices, including removing “clinically proven” from the labels and social media, websites, and other advertising.

click Here to read about other settlement cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!